ACCEPTED MANUSCRIPT Prenatal inflammation exposure-programmed cardiovascular diseases and potential prevention Youcai Denga,b,1,*, Liang Songa,b,1, Xuqiang Niea,b, Weinian Shoua,b,c, Xiaohui Lia,b,* aInstitute of Materia Medica, College of Pharmacy, Army Medical University (Third Military Medical University), 30# Gaotanyan Rd., Shapingba District, Chongqing 400038, China bCenter of Translational Medicine, College of Pharmacy, Army Medical University (Third Military Medical University), 30# Gaotanyan Rd., Shapingba District, Chongqing 400038, China cHerman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, 1044 W. Walnut Street, R4 W302D, Indianapolis, IN 46202, USA 1These authors equally contributed to this work. *Address correspondence to: Xiaohui Li and Youcai Deng Address: Room 606, Pharmaceutical Sciences Building, 30# Gaotanyan Rd, Shapingba District, Chongqing 400038, China Tel.: (86) 23-68771632;ACCEPTED MANUSCRIPT Fax: (86)23-68753397 Email address:
[email protected] (Y. Deng);
[email protected] (X. Li) ___________________________________________________________________ This is the author's manuscript of the article published in final edited form as: Deng, Y., Song, L., Nie, X., Shou, W., & Li, X. (n.d.). Prenatal inflammation exposure-programmed cardiovascular diseases and potential prevention. Pharmacology & Therapeutics. https://doi.org/10.1016/j.pharmthera.2018.05.009 ACCEPTED MANUSCRIPT Abstract In recent years, the rapid development of medical and pharmacological interventions has led to a steady decline in certain noncommunicable chronic diseases (NCDs), such as cancer. However, the overall incidence of cardiovascular diseases (CVDs) has not seemed to decline. CVDs have become even more prevalent in many countries and represent a global health threat and financial burden.